Topics
High-grade gliomas | Treatment | Immunotherapy | Nivolumab
Home > Publications > Topics > High-grade gliomas > Treatment > Immunotherapy > Nivolumab
Santos JN, Batista FS, Sanches F, Miranda A, Santiago M,
Castanheira B, Gonçalves-Nobre JG, Lima P, Nogueira FS,
Brito J.
Exceptional Long-Term Disease
Stability Under Nivolumab in Recurrent High-Grade Glioma: A Case
Report.
Cureus.
2026 Jun 16;18(6):e110942. doi:
10.7759/cureus.110942. PMID:
42465174. ˍ